Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 18 March

 
 
 
   

19 Conversations | The EFPIA podcast series
 
Podcast: Is intellectual property a barrier to access?
Today we're asking Prof. Dr. Walter Van Dyck, Director of Healthcare Management Centre, Vlerick Business School:

"Is intellectual property a barrier to access?".

IP is the key driver of innovation. It has enabled unprecedented collaborations between biopharmaceutical innovators and governments, universities and other research partners to speed up progress on hundreds of potential COVID-19 treatments, diagnostics and vaccines for patients.


 Read more


 
 
 
   

From our blog
 

Why I am #TeamVaccines (Guest blog)
18 March 2021 - Paul Robinson

Dr Paul Robinson from MSD spends 2-3 half days a week vaccinating people against COVID-19, and says the sense of relief... Read more

IMI Impact: Driving healthcare’s digital future
16 March 2021 - Magda Chlebus

The Innovative Medicines Initiative is making it easier to share and use health data for research and care Read more

That's why I am #TeamVaccines
12 March 2021 - Andy Powrie-Smith

It is together, by being part of this unprecedented vaccination programme, that we can all play a role in reconnecting... Read more
 
 
 
   

Videos
 
Accelerating innovation key to ensuring that no one is left behind
This is how innovation works. You foster, incentivise and support a broad research ecosystem so that science can... Read more
Mission Possible: The Race for a Vaccine
Facing a deadly new virus infecting millions of people, Pfizer’s bold plan to create the first COVID-19 vaccine... Read more
 
 
 
   

Events
 

EFPIA – FIFARMA webinar on new procedures and policies for the Certificate of Pharmaceutical...
23 March 2021 (Virtual Event)

This Webinar aims to provide a platform for discussion of new policies, procedures and trends in use of CPP/eCPP Read more

Are current investments in medical research focusing on unmet health needs?
26 March 2021 (Virtual event)

This EFPIA event will explore the results of pharmaceutical industry investment in research and development. Read more
 
 
 
   

This week we are supporting #BrainAwarenessWeek


More than 20 Innovative Medicines Initiative projects are helping advance dementia research: Read our blog
 
 
 
 
   

What we are reading
 
Vaccini in Europa: Tensioni, stop e ritardi
On 18 March 2021 (Rai News)

Ne abbiamo parlato con Sibilia Quilici, direttore esecutivo di Vaccines Europe, gruppo specializzato sui vaccini all’interno... Read more
COVID-19 Vaccine Manufacturing: DCVMN's contribution to the global scale-up
On 16 March 2021 (Gavi)

The COVID-19 pandemic has had a devastating impact on global public health, resulting not only in economic regression... Read more
Perspectives on Value Frameworks in Alzheimer’s Disease
On 15 March 2021 (ISPOR)

Globally, 50 million people are living with Alzheimer’s disease and related dementias (ADRD) and by mid-century, an... Read more
How competition nearly killed Alzheimer’s research
On 15 March 2021 (IMI)

Repeat failures put the brakes on research until the pharma industry regrouped in a new, non-competitive, way. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer